Bone Marrow Transplant Studies for Safe and Effective Treatment of Leukemia

NACompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

March 27, 1997

Primary Completion Date

January 31, 2008

Study Completion Date

August 3, 2017

Conditions
Graft vs Host DiseaseHematologic NeoplasmLeukemiaMultiple MyelomaMyelodysplastic Syndrome
Interventions
PROCEDURE

Allogeneic Bone Marrow Transplant

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH